334 related articles for article (PubMed ID: 23915332)
1. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
2. Intralesional agents in the management of cutaneous malignancy: a review.
Good LM; Miller MD; High WA
J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
[TBL] [Abstract][Full Text] [Related]
3. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
4. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
[No Abstract] [Full Text] [Related]
7. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
8. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.
Kim KH; Yavel RM; Gross VL; Brody N
Dermatol Surg; 2004 Jan; 30(1):116-20. PubMed ID: 14692941
[TBL] [Abstract][Full Text] [Related]
9. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
Panther D; Nino T; Macknet KD; Macknet C
Dermatol Surg; 2015 Jan; 41(1):172-5. PubMed ID: 25533164
[No Abstract] [Full Text] [Related]
10. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
[TBL] [Abstract][Full Text] [Related]
13. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy.
Gracia-Cazaña T; Salazar N; Zamarrón A; Mascaraque M; Lucena SR; Juarranz Á
Actas Dermosifiliogr; 2016 Nov; 107(9):740-750. PubMed ID: 27436804
[TBL] [Abstract][Full Text] [Related]
14. Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Sullivan TJ
Curr Opin Ophthalmol; 2012 Sep; 23(5):439-42. PubMed ID: 22828167
[TBL] [Abstract][Full Text] [Related]
15. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
16. Do lasers or topicals really work for nonmelanoma skin cancers?
Brightman L; Warycha M; Anolik R; Geronemus R
Semin Cutan Med Surg; 2011 Mar; 30(1):14-25. PubMed ID: 21540017
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
18. RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
Gil-Lianes J; Morgado-Carrasco D
Actas Dermosifiliogr; 2023 Mar; 114(3):255-256. PubMed ID: 36113608
[No Abstract] [Full Text] [Related]
19. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
[TBL] [Abstract][Full Text] [Related]
20. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
Desai T; Chen CL; Desai A; Kirby W
Dermatol Surg; 2012 Jan; 38(1):97-103. PubMed ID: 22092926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]